Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?
- PMID: 28186552
- DOI: 10.1093/ndt/gfw432
Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?
Comment on
-
Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.Nephrol Dial Transplant. 2017 Feb 1;32(2):279-287. doi: 10.1093/ndt/gfw418. Nephrol Dial Transplant. 2017. PMID: 28186540 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
